Leggett Thomas sold STOK
March 18, 2026 · Form 4 insider transaction
Leggett Thomas sold 37 shares of Stoke Therapeutics, Inc. at $32.85 per share, a transaction worth $1.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
37
Price
$32.85
Total value
$1.2K
InsiderLeggett Thomas
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 18, 2026
Filing dateMarch 19, 2026
Shares owned after10,172
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units.